Zusammenfassung
Asthma im Kindesalter tritt weltweit mit zunehmender Prävalenz auf. Insbesondere die Industrienationen sind von dieser Entwicklung betroffen. Die Komplexität der Erkrankung, deren Genese von zahlreichen endogenen und exogenen Faktoren abhängt, erschwert die Entschlüsselung der Ursachen dieser beunruhigenden Entwicklung. Seit Entstehung der Hygienehypothese vor etwa 30 Jahren, die den Rückgang der mikrobiellen Stimulation durch Infektionen als Risikofaktor postulierte, wurden zahlreiche Einflussfaktoren untersucht. In groß angelegten Bauernhofstudien konnten Stallhaltung von Tieren und Konsum von unbehandelten Milchprodukten als präventive Faktoren identifiziert werden. Als zugrunde liegender Pathomechanismus wurden eine Stimulation und Regulation des Immunsystems in seiner prä- und postnatalen Entwicklung durch mikrobielle Vielfalt, Allergen- und Endotoxinexposition sowie durch die besondere Zusammensetzung der unbehandelten Kuhmilch beschrieben. Während die Exposition gegenüber protektiven Substanzen in der Umwelt aufgrund der zahlreichen Komponenten und der schwierigen Umsetzbarkeit noch keinen Einzug in den klinischen Alltag gefunden hat, spielen die Erkenntnisse zu un- oder teilbehandelten Milchprodukten eine zunehmende Rolle als mögliche Strategien in der Prävention des Asthmas im Kindesalter.
Abstract
The prevalence of childhood asthma is increasing worldwide. Industrial nations are particularly affected by this development. The complexity of the disease, the genesis of which depends on numerous endogenous and exogenous factors, makes it difficult to decipher the causes of this worrying development. With the emergence of the hygiene hypothesis some 30 years ago, which postulated the decline in microbial stimulation by infections as a risk factor, numerous influencing factors were examined. In large-scale farm studies, animal husbandry and consumption of untreated dairy products could be identified as preventive factors. The underlying pathomechanism was described as stimulation and regulation of the immune system in its prenatal and postnatal development through microbial diversity, allergen and endotoxin exposure as well as the special composition of untreated cow’s milk. While exposure to protective substances in the environment has not yet found its way into everyday clinical practice due to the numerous influencing components and the difficult feasibility, the findings on untreated or partially treated dairy products play an increasing role as possible strategies in the prevention of childhood asthma.
Literatur
(2017) https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm. Zugegriffen: Internet
Network GA (2018) The Global Asthma Report 2018. New Zealand, Auckland
Berger A (2000) Th1 and Th2 responses: What are they? BMJ 321:424. https://doi.org/10.1136/bmj.321.7258.424
Holt PG, Clough JB, Holt BJ, Baron-Hay MJ, Rose AH, Robinson BW et al (1992) Genetic “risk” for atopy is associated with delayed postnatal maturation of T‑cell competence. Clin Exp Allergy 22:1093–1099. https://doi.org/10.1111/j.1365-2222.1992.tb00135
Holt PG, Upham JW, Sly PD (2005) Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 116:16–24. https://doi.org/10.1016/j.jaci.2005.04.017 (quiz 25)
Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296:490–494. https://doi.org/10.1126/science.296.5567.490
Lee J‑H, Yu H‑H, Wang L‑C, Yang Y‑H, Lin Y‑T, Chiang B‑L (2007) The levels of CD4 + CD25+ regulatory Tcells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 148:53–63
Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ, Griese M, Krauss-Etschmann S (2007) Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 119:1258–1266
Kortekaas Krohn I, Shikhagaie MM, Golebski K, Bernink JH, Breynaert C, Creyns B et al (2018) Emerging roles of innate lymphoid cells in inflammatory diseases: clinical implications. Allergy 73:837–850. https://doi.org/10.1111/all.13340
Morita H, Moro K, Koyasu S (2016) Innate lymphoid cells in allergic and nonallergic inflammation. J Allergy Clin Immunol 138:1253–1264. https://doi.org/10.1016/j.jaci.2016.09.011
Davies LC, Jenkins SJ, Allen JE, Taylor PR (2013) Tissue-resident macrophages. Nat Immunol 14:986–995. https://doi.org/10.1038/ni.2705
Gour N, Lajoie S (2016) Epithelial cell regulation of allergic diseases. Curr Allergy Asthma Rep 16:65. https://doi.org/10.1007/s11882-016-0640-7
Krusche J, Basse S, Schaub B (2020) Role of early life immune regulation in asthma development. Semin Immunopathol 42(1):29–42. https://doi.org/10.1007/s00281-019-00774-z
Pfefferle PI, Buchele G, Blumer N, Roponen M, Ege MJ, Krauss-Etschmann S et al (2010) Cord blood cytokines are modulated by maternal farming activities and consumption of farm dairy products during pregnancy: the PASTURE Study. J Allergy Clin Immunol 125(1):108–115 (e1–e3)
Douwes J, Cheng S, Travier N, Cohet C, Niesink A, McKenzie J et al (2008) Farm exposure in utero may protect against asthma, hay fever and eczema. Eur Respir J 32(3):603–611
Schaub B, Liu J, Hoppler S, Schleich I, Huehn J, Olek S et al (2009) Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J Allergy Clin Immunol 123(4):774–782 (e5)
Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson WO, Braun-Fahrlander C et al (2011) Exposure to environmental microorganisms and childhood asthma. N Engl J Med 364(8):701–709
Frei R, Ferstl R, Roduit C et al (2018) Exposure to nonmicrobial N‑glycolylneuraminic acid protects farmers’ children against airway inflammation and colitis. J Allergy Clin Immunol 141(1):382–390.e7. https://doi.org/10.1016/j.jaci.2017.04.051
Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L et al (2002) Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347(12):869–877
Schram D, Doekes G, Boeve M, Douwes J, Riedler J, Ublagger E et al (2005) Bacterial and fungal components in house dust of farm children, Rudolf Steiner school children and reference children—the PARSIFAL Study. Allergy 60(5):611–618
Loss G, Depner M, Ulfman LH et al (2015) Consumption of unprocessed cow’s milk protects infants from common respiratory infections. J Allergy Clin Immunol 135(1):56–62. https://doi.org/10.1016/j.jaci.2014.08.044
Chen CM, Morgenstern V, Bischof W et al (2008) Dog ownership and contact during childhood and later allergy development. Eur Respir J 31:963–973
Salminen S, van Loveren H (2012) Probiotics and pre-biotics: health claim substantiation. Microb Ecol Health Dis. https://doi.org/10.3402/mehd.v23i0.18568 (eCollection 2012)
Azad MB, Coneys JG, Kozyrskyj AL et al (2013) Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ 347:f6471. https://doi.org/10.1136/bmj.f6471
Bisgaard H, Stokholm J, Chawes BL et al (2016) Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring. N Engl J Med 375:2530–2539
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
E. von Mutius: During the 36 months prior to publication, Dr. Erika von Mutius reports to have received personal fees from Pharmaventures, from OM Pharma S. A., from Springer-Verlag GmbH, from Elsevier GmbH and Elsevier Ltd., from Peptinnovate Ltd., from Turun Yliopisto, from Tampereen Yliopisto, from Helsingin Yliopisto, from European Respiratory Society, from Deutsche Pharmazeutische Gesellschaft e. V., from Massachusetts Medical Society, from Chinese University of Hongkong, from European Commission, from Böhringer Ingelheim International GmbH, from Universiteit Utrecht, Faculteit Diergeneeskunde, from Universität Salzburg, from Georg Thieme Verlag, from Japanese Society of Pediatric Allergy and Clinical Immunology (JSPACI), outside the submitted work; In addition, Dr. von Mutius has a patent LU101064 – Barn dust extract for the prevention and treatment of diseases pending, a patent EP2361632: Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune disorders with royalties paid to ProtectImmun GmbH, a patent Publication number EP 1411977: Composition containing bacterial antigens used for the prophylaxis and the treatment of allergic diseases. licensed to ProtectImmun GmbH, a patent Publication number EP1637147: Stable dust extract for allergy protection licensed to ProtectImmun GmbH, and a patent Publication number EP 1964570: Pharmaceutical compound to protect against allergies and inflammatory diseases licensed to ProtectImmun GmbH. N. Maison und S. Pechlivanis geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
G. Hansen, Hannover
Rights and permissions
About this article
Cite this article
Maison, N., Pechlivanis, S. & von Mutius, E. Prävention von Asthma im Kindesalter. Was bedeutet der Bauernhofeffekt für die Praxis?. Monatsschr Kinderheilkd 168, 988–994 (2020). https://doi.org/10.1007/s00112-020-00992-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-020-00992-y